ProStrakan Group plc, a subsidiary of Kyowa Hakko Kirin Co. Ltd. and an international specialty pharmaceutical company, announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Rectiv (nitroglycerin) Ointment 0.4% for the...